Spero Therapeutics SPRO
NASDAQ SPRO
$1.11 -0.02 (-1.77%)
At close: Oct 23, 2026 · 4:00 PM EDT

Spero Therapeutics (SPRO) Gains from Investment Securities (2016 - 2022)

Updated

Analysis

Spero Therapeutics (SPRO) Gains from Investment Securities (2016 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Spero Therapeutics 63.77 Mn -132.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 141,000.00
Sep 30, 2022 -26,000.00
Jun 30, 2022 995,000.00
Mar 31, 2022 -193,000.00
Dec 31, 2021 204,000.00
Dec 31, 2019 222,000.00
Mar 31, 2019 1,000.00
Dec 31, 2017 -3.09 Mn
Sep 30, 2017 -2,000.00
Jun 30, 2017 350,000.00
Mar 31, 2017 1.20 Mn
Dec 31, 2016 -543,000.00
Sep 30, 2016 -4,000.00
API Access

Spero Therapeutics Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=SPRO&period=max&api_key=YOUR_API_KEY